share_log

Biora Therapeutics Says On Jan. 19, 2023 Co. Received Notice Of Delisting Or Failure To Satisfy Continued Listing Rule Or Standard From Nasdaq

Biora Therapeutics Says On Jan. 19, 2023 Co. Received Notice Of Delisting Or Failure To Satisfy Continued Listing Rule Or Standard From Nasdaq

比奧拉治療學說,1 月 19 日,2023 有限公司。收到納斯達克除牌或未能符合持續上市規則或標準的通知
Benzinga Real-time News ·  2023/01/20 16:12

Biora Therapeutics Says On Jan. 19, 2023 Co. Received Notice Of Delisting Or Failure To Satisfy Continued Listing Rule Or Standard From Nasdaq

比奧拉治療學說,1 月 19 日,2023 有限公司。收到納斯達克除牌或未能符合持續上市規則或標準的通知

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論